GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nuwellis Inc (NAS:NUWE) » Definitions » Gross Margin %
中文

Nuwellis (Nuwellis) Gross Margin % : 54.41% (As of Dec. 2023)


View and export this data going back to 2012. Start your Free Trial

What is Nuwellis Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Nuwellis's Gross Profit for the three months ended in Dec. 2023 was $1.39 Mil. Nuwellis's Revenue for the three months ended in Dec. 2023 was $2.55 Mil. Therefore, Nuwellis's Gross Margin % for the quarter that ended in Dec. 2023 was 54.41%.


The historical rank and industry rank for Nuwellis's Gross Margin % or its related term are showing as below:

NUWE' s Gross Margin % Range Over the Past 10 Years
Min: 22.23   Med: 53.13   Max: 56.7
Current: 56.22


During the past 13 years, the highest Gross Margin % of Nuwellis was 56.70%. The lowest was 22.23%. And the median was 53.13%.

NUWE's Gross Margin % is ranked better than
54.77% of 796 companies
in the Medical Devices & Instruments industry
Industry Median: 53.54 vs NUWE: 56.22

Nuwellis had a gross margin of 54.41% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Nuwellis was 12.10% per year.


Nuwellis Gross Margin % Historical Data

The historical data trend for Nuwellis's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuwellis Gross Margin % Chart

Nuwellis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 51.73 54.52 56.70 55.66 56.22

Nuwellis Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 56.90 58.43 55.28 57.26 54.41

Competitive Comparison of Nuwellis's Gross Margin %

For the Medical Devices subindustry, Nuwellis's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nuwellis's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nuwellis's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Nuwellis's Gross Margin % falls into.



Nuwellis Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Nuwellis's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=5 / 8.864
=(Revenue - Cost of Goods Sold) / Revenue
=(8.864 - 3.881) / 8.864
=56.22 %

Nuwellis's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=1.4 / 2.551
=(Revenue - Cost of Goods Sold) / Revenue
=(2.551 - 1.163) / 2.551
=54.41 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Nuwellis  (NAS:NUWE) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Nuwellis had a gross margin of 54.41% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Nuwellis Gross Margin % Related Terms

Thank you for viewing the detailed overview of Nuwellis's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Nuwellis (Nuwellis) Business Description

Traded in Other Exchanges
Address
12988 Valley View Road, Eden Prairie, MN, USA, 55344
Nuwellis Inc is a medical device company. Its solutions include Aquadex Smartflow System and RenalSense Clarity RMS. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Clarity RMS is a kidney monitoring system that continuously measures urine output and flows, automatically displaying real-time data to the medical staff.
Executives
David Mcdonald director 6 KEMPTON PLACE, #12, SARATOGA SPRINGS NY 12866
Archelle Georgiou Feldshon director 1420 SHORELINE DRIVE, WAYZATA MN 55391
Robert Benjamin Scott officer: Chief Financial Officer 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Michael Kendrick Mccormick director 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Gregory D Waller director 1717 W COLLINS AVENUE, ORANGE CA 92867
Jon W Salveson director 800 NICOLLET MALL, MINNEAPOLIS MN 55402
Nestor Jr. Jaramillo officer: Chief Commercial Officer 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Lynn Larson Blake officer: Chief Financial Officer 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
George Montague officer: CFO and Treasurer 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Neil P Ayotte officer: SVP, Secretary, GC & CCO 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Paul Wotta officer: Principal Accounting Officer 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Claudia Drayton officer: Chief Financial Officer 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Thomas P. Lynch officer: Chief Legal/Compliance Officer 3344 N. TORREY PINES COURT, LA JOLLA CA 92037
Steven Frank Brandt director 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Maria Rosa Costanzo director 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344